Published in Ann Saudi Med on August 13, 2004
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene (2003) 2.51
Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst (2011) 2.18
Prognostic factors affecting the outcome of brain metastases from breast cancer. Support Care Cancer (2006) 2.17
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell (2006) 2.13
Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol (2010) 1.56
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res (2004) 1.48
Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix. Gynecol Oncol (2010) 1.48
Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol (2003) 1.46
Sitting position does not alter minimum alveolar concentration for desflurane. Can J Anaesth (2007) 1.42
Submucous myoma induces uterine inversion. Taiwan J Obstet Gynecol (2006) 1.33
Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma. Cancer Res (2006) 1.25
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol (2004) 1.23
Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol (2009) 1.17
Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol (2007) 1.16
A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Cancer Res (2005) 1.12
Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci (2005) 1.12
Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis. Mol Ther (2010) 1.11
Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases. Ann Saudi Med (2005) 1.10
Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol Oncol (2005) 1.09
Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol (2004) 1.09
Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol (2010) 1.04
Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor. Anticancer Res (2007) 1.04
Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Int J Cancer (2010) 1.03
Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology (2008) 1.02
Ruptured pseudoaneurysm of the external iliac artery in an advanced cervical cancer patient treated by endovascular covered stent placement. J Formos Med Assoc (2008) 1.01
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. Biochem J (2009) 1.01
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Carcinogenesis (2004) 1.00
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response. Mol Oncol (2011) 1.00
The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions. J Psychosom Obstet Gynaecol (2010) 0.93
Generation and characterization of an ascitogenic mesothelin-expressing tumor model. Cancer (2007) 0.93
Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. Oncogene (2005) 0.92
Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res (2013) 0.92
Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects. Cancer Res (2005) 0.91
Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women. Int J Cancer (2010) 0.87
Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol (2005) 0.87
Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinoma. Int J Gynecol Cancer (2010) 0.87
Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer. Oral Oncol (2010) 0.86
Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis. Mol Ther (2005) 0.86
Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies. Hum Reprod (2002) 0.86
Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia. J Formos Med Assoc (2009) 0.86
Comparison of 3 video laryngoscopes with the Macintosh in a manikin with easy and difficult simulated airways. Am J Emerg Med (2012) 0.86
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway. Mol Ther (2005) 0.85
Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. Immunology (2005) 0.85
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis. Vaccine (2004) 0.85
Chemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer. Adv Ther (2011) 0.85
Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study. J Med Virol (2005) 0.84
Comparison of dexamethasone with ondansetron or haloperidol for prevention of patient-controlled analgesia-related postoperative nausea and vomiting: a randomized clinical trial. World J Surg (2012) 0.82
Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk. Cancer (2011) 0.82
Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system. Arch Gynecol Obstet (2010) 0.82
Accuracy of the convolution/superposition dose calculation algorithm at the condition of electron disequilibrium. Appl Radiat Isot (2002) 0.81
Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan. Gan To Kagaku Ryoho (2002) 0.81
Effectiveness of a pilot project of discharge planning in Taiwan. Res Nurs Health (2003) 0.81
Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin. Int J Cancer (2008) 0.81
Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan. Acta Obstet Gynecol Scand (2011) 0.81
DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens. Gynecol Oncol (2007) 0.81
Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan. J Med Virol (2013) 0.81
Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Support Care Cancer (2009) 0.80
Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma. J Formos Med Assoc (2002) 0.80
The effect of a metal hip prosthesis on the radiation dose in therapeutic photon beam irradiations. Appl Radiat Isot (2002) 0.79
Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma. Int J Gynaecol Obstet (2010) 0.79
Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis. Fetal Diagn Ther (2005) 0.79
Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways. Eur J Immunol (2004) 0.78
Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc (2004) 0.78
Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix. Gynecol Oncol (2010) 0.78
Surface dose with grids in electron beam radiation therapy. Appl Radiat Isot (2002) 0.78
Clear cell adenocarcinoma of the uterine cervix. Taiwan J Obstet Gynecol (2007) 0.78
Prognostic factors affecting the outcome of brain metastases from breast cancer. Support Care Cancer (2006) 0.78
Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma. Acta Obstet Gynecol Scand (2004) 0.77
Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan. Cancer Causes Control (2010) 0.77
Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients. Endocr Relat Cancer (2013) 0.77
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix. Oncol Res (2009) 0.77
Proinflammatory macrophage migratory inhibition factor and interleukin-6 are concentrated in pleural effusion of human fetuses with prenatal chylothorax. Prenat Diagn (2007) 0.77
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum. Gynecol Oncol (2008) 0.77
High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions. Taiwan J Obstet Gynecol (2013) 0.76
Sixteen years post radiotherapy of nasopharyngeal carcinoma elicited multi-dysfunction along PTX and chronic kidney disease with microcytic anemia. BMC Urol (2014) 0.75
Study of induced thermoluminescence in CVD diamond film by low-energy X-rays. Appl Radiat Isot (2003) 0.75
Evaluation of the longitudinal contraction of the ventricle septum in patients undergoing off-pump coronary artery bypass graft surgery by strain rate imaging. Acta Anaesthesiol Taiwan (2006) 0.75
Evaluating the Radiation From Accidental Exposure During a Nondestructive Testing Event. Health Phys (2015) 0.75
Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer. Gan To Kagaku Ryoho (2010) 0.75
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma. Anticancer Res (2008) 0.75
Effect of cigarette smoking on bone mineral density in healthy Taiwanese middle-aged men. J Clin Densitom (2008) 0.75
Quantitative ultrasound of the calcaneus in hemodialysis patients. Ultrasound Med Biol (2010) 0.75
Monte Carlo simulation of surface percent depth dose. Appl Radiat Isot (2002) 0.75
Is unenhanced 18F-FDG-PET/CT better than enhanced CT in the detection of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma? Ear Nose Throat J (2016) 0.75
Indoor light on thermoluminescence of CVD diamond film used as a high-energy photon dosimeter. Appl Radiat Isot (2003) 0.75